Journal of Clinical Ophthalmology - Dove Medical Press:The results from this small study suggests that nepafenac 0.1% may have activity against diabetic macular edema in a significant way.
Thursday, November 20, 2008
NEVANAC IMPROVES CSME
Journal of Clinical Ophthalmology - Dove Medical Press:The results from this small study suggests that nepafenac 0.1% may have activity against diabetic macular edema in a significant way.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Leave a Comment or Question: